Drug Information

Drug General Information
Drug ID
D01JTL
Former ID
DIB012686
Drug Name
KM-023
Indication Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] Phase 1 [523464]
Company
Kainos Medicine Inc
Target and Pathway
Target(s) HIV reverse transcriptase Target Info Inhibitor [532985]
References
Ref 523464ClinicalTrials.gov (NCT01348516) Single Ascending Dose (SAD)/Multiple Ascending Dose(MAD) Safety/Pharmacokinetic (PK) Study of KM-023. U.S. National Institutes of Health.
Ref 532985Pharmacokinetics and tolerability of the new second-generation nonnucleoside reverse- transcriptase inhibitor KM-023 in healthy subjects. Drug Des Devel Ther. 2014 Sep 26;8:1613-9.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.